Stock listing

Stockholm:NEWBRY Newbury Pharmaceuticals AB Aktie

Home listing (Stockholm) of Newbury Pharmaceuticals AB

Follow Newbury Pharmaceuticals AB into a list and get an email when it puts out news.

Share price · OMXSTO:NEWBRY

2.03 SEK -0.05 (-2.4%)

Close on Oct 19, 2026

Past 3 months -0.5% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
1.97 – 2.04 SEKOct 19, 2026
Volume
9,025 sharesOct 19, 2026
Market value
61.71M SEKAt the close on Oct 19, 2026 · price × 30.40M shares outstanding
Newbury Pharmaceuticals AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:NEWBRY · Home2.03 SEK-0.05 (-2.4%)9,0252.022.041.972.08Close on Oct 19, 2026
Frankfurt:P52€0.125 EUR+0.002 (+1.6%)—€0.178€0.178€0.122€0.123Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · OMXSTO:NEWBRY · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.03-0.05-2.4%2.022.041.979,025
2.080.000.0%2.082.082.084,365
2.08-0.11-5.0%2.132.132.0529,844
2.19-0.06-2.7%2.222.262.1427,481
2.25+0.05+2.3%2.132.252.133,895
2.20-0.01-0.5%2.202.212.147,761
2.210.000.0%2.212.212.210
2.21+0.01+0.5%2.142.212.141,175
2.20+0.08+3.8%2.122.202.0832,624
2.12-0.10-4.5%2.142.142.1010,680
2.220.000.0%2.222.222.2250
2.22-0.01-0.4%2.232.262.1088,268
2.23-0.08-3.5%2.302.312.2136,201
2.31+0.02+0.9%2.232.312.233,634
2.29+0.02+0.9%2.272.292.274,861
2.27-0.04-1.7%2.312.312.1928,871
2.31+0.01+0.4%2.242.312.241,986
2.300.000.0%2.232.382.2312,684
2.30+0.20+9.5%2.112.302.1129,250
2.10-0.15-6.7%2.172.182.1017,775
2.25-0.13-5.5%2.422.422.2318,684
2.38+0.13+5.8%2.242.382.1822,000
2.25+0.03+1.4%2.172.252.146,371
2.22-0.20-8.3%2.342.502.1273,038
2.42+0.08+3.4%2.352.422.354,647
2.34-0.16-6.4%2.512.512.347,280
2.50-0.01-0.4%2.442.502.415,826
2.51+0.14+5.9%2.382.512.3830,642
2.37+0.11+4.9%2.292.372.2921,000
2.26+0.07+3.2%2.262.262.203,351
2.19-0.21-8.8%2.312.392.1930,684
2.40-0.01-0.4%2.322.402.329,288
2.41+0.02+0.8%2.412.412.32752
2.39-0.10-4.0%2.492.492.399,442
2.49-0.02-0.8%2.512.532.4238,595
2.51+0.01+0.4%2.512.512.51105
2.50+0.02+0.8%2.482.522.1184,735
2.48-0.12-4.6%2.502.652.3853,949
2.60+0.03+1.2%2.573.472.54154,493
2.57+0.13+5.3%2.432.572.4334,630
2.44-0.30-10.9%2.742.742.38129,781
2.74+0.30+12.3%2.442.742.4460,882
2.44+0.07+3.0%2.372.442.377,158
2.37-0.22-8.5%2.502.582.3719,308
2.59+0.01+0.4%2.662.662.5117,606
2.58-0.14-5.1%2.733.002.44154,210
2.72-0.16-5.6%2.862.862.6833,540
2.88+0.16+5.9%2.762.882.6953,183
2.72+0.03+1.1%2.702.782.7031,266
2.69-0.01-0.4%2.712.712.622,987
2.700.000.0%2.702.702.6194
2.70-0.07-2.5%2.692.962.6068,077
2.77+0.04+1.5%2.732.772.6026,933
2.73-0.07-2.5%2.762.802.708,893
2.80+0.08+2.9%2.782.802.7012,517
2.72-0.08-2.9%2.812.902.6257,081
2.80+0.10+3.7%2.702.802.7028,539
2.70-0.05-1.8%2.802.802.6020,938
2.75+0.03+1.1%2.692.752.6611,785
2.72-0.18-6.2%2.902.902.6734,338
2.90+0.30+11.5%2.603.102.60105,770
2.60+0.11+4.4%2.492.652.4813,542
2.49-0.16-6.0%2.552.742.4237,846
2.65+0.15+6.0%2.322.742.0191,426
2.500.000.0%2.502.502.500
2.500.000.0%2.502.502.411,355
Ticker
Stockholm:NEWBRY
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Stockholm
Currency
SEK

What changed lately

Latest news

Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio in Iraq

Sep 28, 2026

Closed 2.27 (-1.7%) on Sep 28, 2026

Newbury Pharmaceuticals accelerates its neuroscience ambitions with a new partnership for Guanfacine tablets

Aug 17, 2026

Closed 2.58 (-5.1%) on Aug 17, 2026

Newbury Pharmaceuticals Secures Generic Approval for Tofacitinib Newbury

Jul 13, 2026

Closed 2.60 (+7.4%) on Jul 13, 2026

Newbury Pharmaceuticals Secures Generic Approval for Dalbavancin Newbury

Jul 10, 2026

Closed 2.42 (+0.8%) on Jul 10, 2026

Newbury Pharmaceuticals Secures Generic Approval for Palbociclib Newbury

Apr 17, 2026

Newbury Pharmaceuticals extends and increases loan agreement to SEK 30m, convenes EGM

Mar 26, 2026

Newbury Pharmaceuticals has entered into a new partnership for Prucalopride tablets

Mar 18, 2026

Newbury Pharmaceuticals Secures 12-Month Pazopanib Tender in Denmark

Jan 29, 2026

Newbury Pharmaceuticals publishes its annual report for 2024/2025

Dec 10, 2025

Newbury Pharmaceuticals appoints its founder Karl Karlsson as new CEO

Nov 11, 2025

All Newbury Pharmaceuticals AB news

Newbury Pharmaceuticals AB on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
12 in the last 12 months · 19 in all · newest Sep 28, 2026 · oldest 2025

Where Newbury Pharmaceuticals AB is listed

ListingExchangeCountryCurrency
Stockholm:NEWBRY · Home listing · This pageStockholmSwedenSEK
Frankfurt:P52FrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Newbury Pharmaceuticals AB.